48,830
edits
Difference between revisions of "Angiomyolipoma"
Jump to navigation
Jump to search
→Epithelioid AML versus Xp11.2 translocation carcinoma
| Line 98: | Line 98: | ||
===Epithelioid AML versus Xp11.2 translocation carcinoma=== | ===Epithelioid AML versus Xp11.2 translocation carcinoma=== | ||
[[ISUP]] recommends:<ref name=pmid25025364/> | [[ISUP]] recommends:<ref name=pmid25025364 >{{cite journal |author=Amin MB, Epstein JI, Ulbright TM, ''et al.'' |title=Best practices recommendations in the application of immunohistochemistry in urologic pathology: report from the international society of urological pathology consensus conference |journal=Am. J. Surg. Pathol. |volume=38 |issue=8 |pages=1017–22 |year=2014 |month=August |pmid=25025364 |doi=10.1097/PAS.0000000000000254 |url=}}</ref> | ||
*PAX8 -ve. | *PAX8 -ve. | ||
**Positive in Xp11.2 translocation carcinoma. | **Positive in Xp11.2 translocation carcinoma. | ||